Charming Medical Limited Class A (MCTA) Balance Sheet
MCTA balance sheet, FY2026
March 31, 2026 · U.S. dollars$9.9M assets = $4.7M liabilities + $5.2M equity
Both columns are drawn to the same scale: what MCTA owns equals what it owes plus shareholders’ equity. Hover a block for its value.
MCTA financial health
Descriptive bands, not a rating. Fiscal FY2026.
MCTA balance sheet trends, FY2023–FY2026
| Metric | Trend | Then | Latest | Change |
|---|---|---|---|---|
| Total assets | $6.4MFY2023 | $9.9MFY2026 | +15.6%/yr | |
| Total liabilities | $7.7MFY2023 | $4.7MFY2026 | −15.1%/yr | |
| Shareholders’ equity | −$1.2MFY2023 | $5.2MFY2026 | — | |
| Cash & short-term investments | $1.9MFY2023 | $6.5MFY2026 | +50.2%/yr | |
| Total debt | $1.8MFY2023 | $1.2MFY2025 | −19.9%/yr | |
| Net cash (debt) | $119,678FY2023 | $1.6MFY2025 | +$1.5M | |
| Working capital | −$3.0MFY2023 | $3.8MFY2026 | +$6.9M | |
| Book value per share | −$0.07FY2023 | $0.30FY2026 | — | |
| Current ratio | 0.57FY2023 | 1.89FY2026 | +1.31 | |
| Shares outstanding | 16.9MFY2023 | 17.2MFY2026 | +0.5%/yr |
Change is the average annual growth (CAGR) or the difference between the first and latest year.
MCTA assets
MCTA liabilities and equity
MCTA debt vs cash
Debt includes short- and long-term borrowings and, where reported, lease obligations.
MCTA balance sheet
| FY2026 | FY2025 | FY2024 | FY2023 | |
|---|---|---|---|---|
| Assets | ||||
| Cash & short-term investments | $6.5M | $2.8M | $2.1M | $1.9M |
| Cash & equivalents | $4.7M | $816,771 | $2.1M | $1.9M |
| Short-term investments | $1.8M | $1.9M | $0 | — |
| Receivables | $201,477 | $579,091 | $1.5M | $2.1M |
| Inventory | $25,623 | $26,797 | $28,151 | $66,332 |
| Other current assets | $1.4M | $0 | $0 | $0 |
| Total current assets | $8.2M | $3.4M | $3.7M | $4.1M |
| Property, plant & equipment (net) | $1.3M | $1.2M | $921,861 | $1.8M |
| Goodwill & intangible assets | $0 | $0 | $0 | $0 |
| Long-term investments | $0 | $0 | $0 | $0 |
| Other non-current assets | $363,050 | $777,935 | $292,582 | $466,527 |
| Total assets | $9.9M | $5.4M | $4.9M | $6.4M |
| Liabilities | ||||
| Accounts payable | $17,200 | $3,480 | $0 | $1,572 |
| Short-term debt | — | $802,606 | $813,129 | $1.3M |
| Deferred revenue | — | $3.5M | $4.5M | $5.6M |
| Total current liabilities | $4.3M | $4.9M | $5.9M | $7.2M |
| Long-term debt | $0 | $0 | $0 | $0 |
| Lease obligations | $722,217 | $846,413 | $518,767 | $1.2M |
| Other long-term liabilities | $355,557 | $358,033 | $148,250 | $484,258 |
| Total liabilities | $4.7M | $5.3M | $6.0M | $7.7M |
| Shareholders' equity | ||||
| Common stock & paid-in capital | — | $1,534 | $1,534 | $1,534 |
| Retained earnings (deficit) | $96,793 | $119,441 | −$1.1M | −$1.2M |
| Accumulated other comprehensive income | — | −$3,569 | $205 | $3,923 |
| Minority interest | — | $0 | −$66,629 | −$110,213 |
| Total shareholders' equity | $5.2M | $49,243 | −$1.1M | −$1.2M |
| Key figures | ||||
| Total debt | — | $1.2M | $961,379 | $1.8M |
| Net cash (debt) | — | $1.6M | $1.1M | $119,678 |
| Working capital | $3.8M | −$1.6M | −$2.2M | −$3.0M |
| Tangible book value | $5.2M | $49,243 | −$1.1M | −$1.2M |
| Book value per share | $0.30 | $0.00 | −$0.06 | −$0.07 |
| Shares outstanding | 17.2M | 16.9M | 16.9M | 16.9M |
| Current ratio | 1.89 | 0.68 | 0.62 | 0.57 |
| Quick ratio | 1.56 | 0.68 | 0.62 | 0.57 |
| Debt / equity | — | 23.57 | — | — |
| Equity / assets | 52.5% | 0.9% | −22.1% | −18.1% |
| Mar '26 | Sep '25 | Mar '25 | Sep '24 | Mar '24 | |
|---|---|---|---|---|---|
| Assets | |||||
| Cash & short-term investments | $6.5M | $2.7M | $2.8M | $2.7M | $2.1M |
| Cash & equivalents | $4.7M | $1.8M | $816,771 | $2.7M | $2.1M |
| Short-term investments | $1.8M | $912,233 | $1.9M | — | $0 |
| Receivables | $201,477 | $139,667 | $579,091 | $587,926 | $1.5M |
| Inventory | $25,623 | $39,977 | $26,797 | $34,150 | $28,151 |
| Other current assets | $1.4M | $60,781 | $0 | $0 | $0 |
| Total current assets | $8.2M | $2.9M | $3.4M | $3.3M | $3.7M |
| Property, plant & equipment (net) | $1.3M | $844,063 | $1.2M | $1.3M | $921,861 |
| Goodwill & intangible assets | $0 | $0 | $0 | $0 | $0 |
| Long-term investments | $0 | $0 | $0 | $0 | $0 |
| Other non-current assets | $363,050 | $1.7M | $777,935 | $756,582 | $292,582 |
| Total assets | $9.9M | $5.5M | $5.4M | $5.4M | $4.9M |
| Liabilities | |||||
| Accounts payable | $17,200 | $0 | $3,480 | $42,515 | $0 |
| Short-term debt | — | — | $802,606 | $895,101 | $813,129 |
| Deferred revenue | — | — | $3.5M | $4.2M | $4.5M |
| Total current liabilities | $4.3M | $5.0M | $4.9M | $5.6M | $5.9M |
| Long-term debt | $0 | $0 | $0 | $0 | $0 |
| Lease obligations | $722,217 | $326,552 | $846,413 | $973,650 | $518,767 |
| Other long-term liabilities | $355,557 | $106,285 | $358,033 | $459,589 | $148,250 |
| Total liabilities | $4.7M | $5.1M | $5.3M | $6.1M | $6.0M |
| Shareholders' equity | |||||
| Common stock & paid-in capital | — | — | $1,534 | $1,534 | $1,534 |
| Retained earnings (deficit) | $96,793 | $46,463 | $119,441 | −$610,827 | −$1.1M |
| Accumulated other comprehensive income | — | — | −$3,569 | −$3,599 | $205 |
| Minority interest | — | $0 | $0 | — | — |
| Total shareholders' equity | $5.2M | $357,972 | $49,243 | −$681,055 | −$1.1M |
| Key figures | |||||
| Total debt | — | — | $1.2M | $1.4M | $961,379 |
| Net cash (debt) | — | — | $1.6M | $1.3M | $1.1M |
| Working capital | $3.8M | −$2.1M | −$1.6M | −$2.3M | −$2.2M |
| Tangible book value | $5.2M | $357,972 | $49,243 | −$681,055 | −$1.1M |
| Book value per share | $0.30 | $0.02 | $0.00 | −$0.04 | −$0.06 |
| Shares outstanding | 17.2M | 16.9M | 16.9M | 16.9M | 16.9M |
| Current ratio | 1.89 | 0.59 | 0.68 | 0.59 | 0.62 |
| Quick ratio | 1.56 | 0.57 | 0.68 | 0.59 | 0.62 |
| Debt / equity | — | — | 23.57 | — | — |
| Equity / assets | 52.5% | 6.6% | 0.9% | −12.7% | −22.1% |
Quarterly columns are labeled by the month the quarter ended. Figures in U.S. dollars as reported (latest annual report filed —); data from EODHD.
MCTA financial position
At the end of fiscal 2026 (March 31, 2026), Charming Medical had total assets of $9.9 million (up 84.3% from a year earlier), total liabilities of $4.7 million and shareholders' equity of $5.2 million. Its current ratio was 1.89.
Related: MCTA income statement, MCTA cash flow statement, MCTA key metrics. See the MCTA stock overview for the latest quote and news.
MCTA balance sheet FAQ
What are Charming Medical's total assets?
Charming Medical reported total assets of $9.9 million at the end of fiscal 2026 (March 31, 2026), compared with $5.4 million a year earlier.
How much cash does Charming Medical have?
Charming Medical held $6.5 million in cash and short-term investments at the end of fiscal 2026.
What is Charming Medical's book value?
Charming Medical's shareholders' equity (book value) was $5.2 million at the end of fiscal 2026, or $0.30 per share.
What is Charming Medical's current ratio?
Charming Medical had current assets of $8.2 million and current liabilities of $4.3 million, a current ratio of 1.89 (it can cover its short-term obligations).